IDB Invest Finances Ancalmo’s Expansion to Strengthen El Salvador’s Pharmaceutical Industry

WASHINGTON - IDB Invest has provided financing of up to $10 million to Salvadoran pharmaceutical company Ancalmo S.A. de C.V. to expand and modernize its production capacity and strengthen its operations in El Salvador.

The financing will support the refurbishment, expansion, and installation of high-efficiency equipment at a new production facility, the acquisition of machinery and equipment, the strengthening of working capital, and other investments aimed at increasing the company's manufacturing capacity.

The project will help strengthen local pharmaceutical production and support Ancalmo's growth plans in El Salvador and across Central America, the Caribbean, and Mexico. It will also expand the company's export capacity, generate formal employment, and strengthen linkages with domestic suppliers.

The financing consists of a loan of up to $10 million, comprising a committed tranche of $8 million and an uncommitted tranche of up to $2 million, with a term of up to 11 years.

"This operation reflects our commitment to supporting a strategic sector such as pharmaceuticals while fostering the growth of Salvadoran companies that create jobs, strengthen local production, and have the potential to compete in regional markets. Through this financing and our technical support, we are helping Ancalmo enter a new phase of expansion with enhanced production capabilities," said Rodrigo Navas, Director of Corporates for Central America, Haiti, Mexico, Panama, and the Dominican Republic at IDB Invest.

In addition to the financing, IDB Invest will support Ancalmo in strengthening its corporate governance practices and provide technical assistance to assess energy self-supply solutions for the new facility. The operation also includes measures to strengthen the company's environmental and social management.

About IDB Invest

IDB Invest, a member of the IDB Group, is a multilateral development bank committed to promoting the economic development of its member countries in Latin America and the Caribbean through the private sector. IDB Invest finances sustainable companies and projects to achieve financial results and maximize economic, social, and environmental development in the region. With a portfolio of $22 billion in assets under management and more than 440 clients in 25 countries, IDB Invest provides innovative financial solutions and advisory services that meet the needs of its clients in a variety of industries. Visit our website: https://www.idbinvest.org/en.

About Ancalmo

Ancalmo S.A. de C.V. is a Salvadoran pharmaceutical company dedicated to the manufacturing and commercialization of pharmaceutical products. The company is committed to delivering medicines that meet international quality standards through a comprehensive approach focused on efficiency, effectiveness, and highly qualified talent. Headquartered in Antiguo Cuscatlán, El Salvador, with a history dating back to 1938, Ancalmo has established a regional presence that includes El Salvador, Guatemala, Honduras, Nicaragua, Costa Rica, Panama, Mexico, Belize, the United States, and the Dominican Republic. Its purpose is to contribute to the well-being of families through reliable pharmaceutical solutions, driven by continuous improvement and a strong commitment to meeting customer needs. Visit its website: www.ancalmo.com.